Bloom Burton Weighs in on Centric Health Corp.’s Q2 2023 Earnings (TSE:CRX)

Centric Health Corp. (TSE:CRX – Get Rating) – Research analysts at Bloom Burton issued their Q2 2023 earnings per share (EPS) estimates for shares of Centric Health in a research report issued to clients and investors on Tuesday, June 6th. Bloom Burton analyst A. Borovina anticipates that the company will post earnings per share of ($0.02) for the quarter. Bloom Burton has a “Buy” rating on the stock. Bloom Burton also issued estimates for Centric Health’s Q3 2023 earnings at ($0.01) EPS, Q4 2023 earnings at $0.00 EPS, FY2023 earnings at ($0.07) EPS, FY2024 earnings at $0.05 EPS and FY2025 earnings at $0.17 EPS.

Get Centric Health alerts:

Separately, Leede Jones Gab reiterated a “buy” rating on shares of Centric Health in a report on Friday, March 10th.

Centric Health Price Performance

Centric Health (TSE:CRX – Get Rating) last posted its earnings results on Thursday, March 9th. The company reported C($0.10) earnings per share for the quarter, missing the consensus estimate of C($0.06) by C($0.04). The company had revenue of C$94.32 million during the quarter, compared to analysts’ expectations of C$94.73 million.

Further Reading

• Hooker Furnishings Discount To Book, A Value Play?
• REV Group Shifts Into High Gear: Double-Digit Upside Ahead
• Can Kirkland’s Cycle Pick Up Again? Earnings May Have An Answer
• Don’t Bet On A Rally In Stitch Fix, Invest In The Future
• 2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values

Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.